Clinical Outcomes in Patients with High-Dose Methotrexate Toxicity Treated with Vs. without Glucarpidase

被引：0
|
作者：
Gupta, Shruti [1 ]
LaCasce, Ann [2 ]
Leaf, Rebecca Karp [3 ]
Kaunfer, Sarah [1 ]
Leaf, David E. [1 ]
机构：
[1] Brigham & Womens Hosp, Div Renal Med, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] GLUCARPIDASE RESCUE IN PATIENTS WITH HIGH-DOSE METHOTREXATE TOXICITY
    Ramos Jesus, Ruiz
    Aguado Jorge, Reig
    Cava Paloma, Escobar
    Briz Eduardo, Lopez
    Jose Luis, Poveda Andres
    ATENCION FARMACEUTICA, 2013, 15 (04): : 295 - 298
  • [2] Glucarpidase following high-dose methotrexate: update on development
    Patterson, Daniel M.
    Lee, Siow Ming
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (01) : 105 - 111
  • [3] Leucovorin pharmacokinetics in patients receiving high dose methotrexate, with or without glucarpidase
    Howard, Scott
    Schwartz, Stefan
    King, Thomas
    Ward, Suzanne
    CLINICAL TOXICOLOGY, 2013, 51 (07) : 585 - 585
  • [4] Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma
    Truong, Huong L.
    Barreto, Jason N.
    Mara, Kristin C.
    Hampel, Paul J.
    Micallef, Ivana N.
    Nowakowski, Grzegorz S.
    Thanarajasingam, Gita
    Thompson, Carrie A.
    Wang, Yucai
    Witzig, Thomas E.
    Herrmann, Sandra M.
    Leung, Nelson
    JCO ONCOLOGY PRACTICE, 2024, 20 (06) : 797 - 807
  • [5] High-Dose Methotrexate (HDMTX) Induced Nephrotoxicity: Glucarpidase or Dialysis?
    Sridhar, Abhinaya
    Malik, Uzma
    Kapoor, Aromma
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 380 - 380
  • [6] Glucarpidase in high-dose methotrexate delayed elimination: Uncertain effectiveness
    Lepoix, E.
    Azzouz, B.
    Michelet-Huot, E.
    Morel, A.
    Trenque, T.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 199 - 200
  • [7] Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy
    Ogawa, Atsushi
    Kawamoto, Hiroshi
    Hara, Junichi
    Kikuta, Atsushi
    Ogawa, Chitose
    Hiraga, Hiroaki
    Yoshimura, Kenichi
    Miyairi, Kazunari
    Omori, Reiko
    Ro, Tokihiro
    Kamei, Yuna
    Kimura, Toshimi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (01) : 89 - 101
  • [8] High-dose MTX intoxication treated with dose-capped glucarpidase
    Engels, F.
    van der Sluis, I
    Dijkman, M.
    Koppen, A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S64 - S65
  • [9] Intravenous radiographic contrast administered prior to high-dose methotrexate and subsequent toxicity requiring the use of glucarpidase
    Schultz, Thomas E.
    Lynch, Alia C.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) : 993 - 997
  • [10] High dose vs. standard dose methotrexate in JIA: Effects on liver toxicity and clinical response.
    Becker, Mara L.
    Cron, Randy Q.
    Lautenbach, Ebbing
    Sherry, David D.
    Rose, Carlos D.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4054 - 4055
12345